NCT07750977

Brief Summary

The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:

  1. 1.Does blood flow restriction training improve neuromuscular function compared with conventional training?
  2. 2.Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
24 days until next milestone

Study Start

First participant enrolled

August 30, 2026

Expected
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

August 6, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

July 25, 2026

Last Update Submit

August 3, 2026

Conditions

Keywords

Blood Flow Restriction TrainingArtistic Jump RopeNeuromuscular Function

Outcome Measures

Primary Outcomes (1)

  • Change in Neuromuscular Function Assessed by Surface Electromyography and Maximal Voluntary Contraction

    Neuromuscular function will be assessed using surface electromyography (sEMG) and maximal voluntary contraction (MVC) testing. Outcome measures include muscle activation amplitude, root mean square (RMS, μV), integrated electromyography (iEMG, μV·s), mean power frequency (MPF, Hz), and maximal voluntary contraction force (N).

    Baseline and after 8 weeks of intervention

Secondary Outcomes (9)

  • Change in Upper Limb Muscle Strength Assessed by Hand Grip Strength Test

    Baseline and after 8 weeks of intervention

  • Change in One-Repetition Maximum Strength

    Baseline and after 8 weeks of intervention

  • Change in Lower Limb Explosive Power Assessed by Three-Dimensional Force Platform

    Baseline and after 8 weeks of intervention

  • Change in Upper Limb Anaerobic Power During Wingate Test

    Baseline and after 8 weeks of intervention

  • Change in Lower Limb Anaerobic Power During Wingate Test

    Baseline and after 8 weeks of intervention

  • +4 more secondary outcomes

Study Arms (2)

Blood Flow Restriction Training Group

EXPERIMENTAL
Behavioral: Blood Flow Restriction Training

Conventional Training Group

ACTIVE COMPARATOR
Behavioral: Conventional Artistic Jump Rope Training

Interventions

An 8-week blood flow restriction training program combined with regular artistic jump rope training. External pressure will be applied using a blood flow restriction device during selected training sessions.

Blood Flow Restriction Training Group

An 8-week conventional artistic jump rope training program without blood flow restriction.

Conventional Training Group

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 18 to 25 years.
  • Current artistic jump rope athletes with at least 2 years of regular artistic jump rope training experience.
  • Participants who are able to perform artistic jump rope skills and complete all study-related assessments and training procedures.
  • Participants who are physically healthy and have no medical conditions that may interfere with exercise testing or blood flow restriction training.
  • Participants who have no acute or chronic musculoskeletal injuries affecting the upper limbs, lower limbs, or trunk.
  • Participants who voluntarily agree to participate and provide written informed consent before enrollment.

You may not qualify if:

  • Participants younger than 18 years or older than 25 years.
  • Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation disorders, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise safety.
  • Presence of acute or chronic musculoskeletal injuries, including injuries involving muscles, joints, ligaments, tendons, or bones, that prevent safe completion of study procedures.
  • Significant pain, severe fatigue, insufficient recovery, poor sleep condition, or other health conditions that may affect exercise performance or participant safety.
  • Use of medications, nutritional supplements, or sports supplements within the previous week that may influence cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance.
  • Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
  • Inability to understand the study procedures or inability to complete required assessments, including physical performance tests, blood flow restriction training, or blood lactate testing.
  • Refusal to participate in blood flow restriction training or withdrawal of informed consent during the study.
  • \. Age younger than 18 years or older than 25 years. 2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation abnormalities, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise testing or blood flow restriction training safety.
  • \. Current acute or chronic injuries involving muscles, joints, ligaments, tendons, or bones that prevent safe completion of study procedures.
  • \. Severe fatigue, poor recovery status, significant pain, insufficient sleep, or other conditions that may influence exercise performance or participant safety.
  • \. Use of medications, nutritional supplements, or sports supplements that may affect cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance within the previous week.
  • \. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
  • \. Inability or unwillingness to complete study assessments, blood flow restriction training, blood lactate testing, or other required procedures.
  • \. Withdrawal of consent or inability to comply with the study protocol during the intervention period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai University of Sport, School of Physical EducationKun

Shanghai, Shanghai Municipality, 200000, China

Location

MeSH Terms

Interventions

Blood Flow Restriction Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • kun Zhu, Professor

    Shanghai University of Sport

    PRINCIPAL INVESTIGATOR
  • Jing Wang, Student

    Shanghai University of Sport

    STUDY DIRECTOR

Central Study Contacts

Shijun Jin, student

CONTACT

Liubin Fu, Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 25, 2026

First Posted

August 6, 2026

Study Start (Estimated)

August 30, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

August 6, 2026

Record last verified: 2026-08

Locations